Dividends Calendar Earnings Calendar
INM

INM | InMed Pharmaceuticals

InMed Pharmaceuticals

    Quick infos

    • Headquarters:   Vancouver, Canada

    Trade prices

    • Volume:
    • Market Cap: 12.83M
    • Prev closed: 3.48
    • Open: 3.7
    • High: 3.75
    • Low: 3.32
    • 52 week low: 3.04
    • 52 week high: 10.63
    • Dividends:No Dividends

    Next ER: February 27, 2023  Before Market Opens



    Top Stories (INM)

      Company Profile

      InMed is a clinical-stage company developing a pipeline of cannabinoid-based pharmaceutical drug candidates, initially focused on the therapeutic benefits of cannabinol (CBN), in diseases with high unmet medical need. The Company is dedicated to delivering new therapeutic alternatives to patients that may benefit from cannabinoid-based pharmaceutical drugs.

      Earnings History

      Date EPS / Forecast Revenue / Forecast
      May 11, 2023
      February 17, 2023-0.91 / -4.5469.78K / 500K
      November 11, 2022-4.06 / -4.25320.79K / 500K
      September 23, 2022-12.22 / -0.29514.8K / 0.97MBeat!
      May 13, 2022-0.25 / -0.25309.59K / 309.59K
      view more

      Historical Data

      DatePriceOpenHighLowVolChangeER
      May 19, 2022 0.790 0.770
      0.850
      0.770
      		 14.52K 1.28%
      May 18, 2022 0.780 0.840
      0.890
      0.768
      		 95.87K -6.04%
      May 17, 2022 0.830 0.785
      0.890
      0.770
      		 54.48K 3.76%
      May 16, 2022 0.800 0.795
      0.810
      0.780
      		 47.84K -3.61%
      May 13, 2022 0.830 0.880
      0.890
      0.800
      		 62.33K 2.47%
      May 12, 2022 0.810 0.797
      0.890
      0.795
      		 91.17K -1.22%
      May 11, 2022 0.820 0.860
      0.865
      0.767
      		 92.15K -5.21%
      May 10, 2022 0.865 0.822
      0.947
      0.800
      		 53.79K 8.49%
      May 9, 2022 0.797 0.910
      0.990
      0.780
      		 95.17K -15.16%
      May 6, 2022 0.940 0.850
      0.965
      0.850
      		 55.85K 5.25%
      view more
      NASDAQ - Nasdaq Stock Market

      News

      News for (INM)

      This company doesn't provide a dividend.

      Key Persons

      • CEO :  Eric A. Adams (16 Jun 2016–)

      Talk about InMed Pharmaceuticals below in comments section below.

      Do you think you'll buy? Do you already have active trades now?

      EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
      This profile is based on publicly available information and is intended to be informative in nature.

      Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




      Other ER on Feb 27, 2023 (Same day)

      uhs aes glp dar oke argo oxy wday hei iipr frpt bmrn 


      Jump to (Finance sites)

      Google   
               

      Their Official Profiles 

      TwitterLinkedIn

      Support this project

      If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
      More features coming soon :)

      Social Media 




      Recommended Books

      The Intelligent Investor
      Buy on Amazon

      Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.

      The best book on investing ever written.
      -- Warren Buffet